Biosensors Market Analysis and Forecast to 2032: By Type (Wearable, Non-wearable), Technology (Electrochemical, Optical, Thermal, Piezoelectric, Others), Medical Application (Blood Glucose Testing, Cholesterol Testing, Blood Gas Analysis, Pregnancy Testing, Drug Discovery, Infectious Disease Testing, Others), End-use (Point of Care Testing, Home Healthcare Diagnostics, Research Laboratories, Others), and Region

The global Biosensors market was valued at approximately USD 26.4 billion in 2022 and it is anticipated to grow further to nearly USD 51.5 billion by 2032, at a CAGR of 6.9% during the forecast period.

Biosensors is a medical devices designed primarily for the detection or measurement of biological substances like biomolecules or microorganisms. These analytical tools are capable of converting biological responses into electrical signals. Comprising three essential components namely, an analyte-identifying unit generating signals, a signal transducer, and a reader device biosensors have diverse applications in areas such as food and beverages, environmental monitoring, and home care diagnostics. They are also utilized in nanomechanical biosensors. Furthermore, biosensor applications extend to plant biology, where they play a crucial role in studying metabolic processes.

Global Biosensors Market Scope and Report Structure

Report AttributeDetails
Market Size in 2022US$ 26.4 Billion
Market Size in 2032US$ 51.5 Billion
CAGR %6.9%
Historic Period2016-2021
Forecast Period2023-2032
Base Year2022
Segments CoveredType, Technology, Application, End-user, and Region.
Key CompaniesThermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Ascensia Diabetes Care Holdings AG, Biosensors International Group, Ltd, Siemens Healthineers AG, Bio-Rad Laboratories, Inc, among others.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments

Market Trends and Drivers

The biosensors market is experiencing significant growth driven by a surge in demand for portable biosensors in the Asia Pacific and European regions. The increasing awareness of the importance of rapid and accurate diagnostics, coupled with the growing prevalence of chronic diseases, has fueled the adoption of biosensors. The portability of these devices offers a convenient and efficient solution for point-of-care testing, enabling healthcare professionals to quickly obtain real-time information. Additionally, the rise in health-conscious consumers and the need for continuous monitoring further contribute to the market expansion. As these regions continue to prioritize advancements in healthcare technology, the biosensors market is poised for sustained growth, with portable biosensors playing a pivotal role in shaping the industry landscape.

Market Restraints and Challenges

The biosensors market in the medical field faces several constraints that hinder its seamless integration and widespread adoption. One significant challenge is the complexity and variability of biological samples, which can lead to issues such as interference and inaccuracies in sensor readings. Additionally, the high cost of biosensor development and the stringent regulatory requirements for medical devices pose financial and time-related barriers for market players. The need for continuous improvement in sensitivity, specificity, and reproducibility of biosensors further adds to the research and development challenges. Moreover, concerns related to data security and privacy, as biosensors often deal with sensitive health information, contribute to the hesitancy in embracing these technologies on a broader scale. Addressing these constraints requires collaborative efforts from researchers, industry stakeholders, and regulatory bodies to enhance the reliability, affordability, and user-friendliness of biosensors for effective integration into the medical field.

Global Biosensors Market Segmental Overview

The global biosensors market is segmented into type, technology, application, end user, and region.

Global Biosensors Market by Type

Based on the type, it is segmented into wearable, and non-wearable. The non-wearable segment in the biosensors market has experienced robust growth driven by technological advancements and increasing applications across diverse industries. Non-wearable biosensors, which include implantable sensors, ingestible sensors, and environmental sensors, have witnessed heightened demand in areas such as healthcare, agriculture, and environmental monitoring. The growing emphasis on continuous, real-time data monitoring and the integration of biosensors into various non-traditional platforms contribute to the segment’s expansion. Additionally, the focus on miniaturization, enhanced sensitivity, and improved communication capabilities further propels the non-wearable biosensors market.

Global Biosensors Market by Technology

Based on the technology, it is segmented into thermal, electrochemical, piezoelectric, and optical.  The biosensors market is experiencing a significant growth trajectory, largely propelled by advancements in optical technology. The integration of cutting-edge optical components has revolutionized biosensor performance, offering enhanced sensitivity, real-time monitoring capabilities, and improved detection accuracy. Optical biosensors leverage principles such as surface plasmon resonance and fluorescence, allowing for the rapid and precise analysis of biological samples. This surge in optical segment growth within the biosensors market is attributed to the continuous innovation in optical materials, sensor design, and signal processing techniques. As a result, these biosensors find diverse applications in medical diagnostics, environmental monitoring, and food safety, fostering a promising growth for the integration of optical technologies in the evolving field of biosensing.

Global Biosensors Market by Application

Based on the application, it is segmented into Blood Glucose Testing, Cholesterol Testing, Blood Gas Analysis, Pregnancy Testing, Drug Discovery, Infectious Disease Testing, and others. The Infectious Disease Testing segment within the biosensors market is experiencing robust growth, driven by an increasing demand for rapid and accurate diagnostic solutions. Biosensors play a pivotal role in detecting infectious diseases by leveraging their ability to detect specific biomolecules associated with pathogens. The ongoing global focus on public health, coupled with the need for timely disease identification, has propelled the adoption of biosensor-based infectious disease testing. These innovative devices offer advantages such as rapid results, portability, and cost-effectiveness, making them indispensable in point-of-care settings and resource-limited environments. Additionally, advancements in sensor technologies, coupled with a growing emphasis on early detection and monitoring, are likely to sustain the momentum in the Infectious Disease Testing segment of the biosensors market, contributing significantly to its continued expansion.

Global Biosensors Market by End User

Based on the end user, it is segmented into Point of Care Testing, Home Healthcare Diagnostics, and Research Laboratories. The Point of Care Testing (POCT) segment within the biosensors market has experienced substantial growth, driven by the increasing demand for rapid and decentralized diagnostic solutions at the end-user level. These biosensors provide healthcare professionals and patients with real-time and on-site testing capabilities, minimizing the turnaround time for critical medical decisions. The convenience and accessibility of POCT biosensors have proven particularly valuable in scenarios where immediate results are crucial, such as emergency care, remote locations, and home healthcare settings. This growth underscores a paradigm shift towards personalized and patient-centric healthcare, emphasizing the significance of biosensors in delivering timely and accurate diagnostic information at the point of need.

Geographical Analysis of the Global Biosensors Market

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North American biosensors market is experiencing substantial growth due to the presence of key players and a high incidence of targeted diseases in the region. Projected advancements in technology, including the introduction of miniaturized diagnostic equipment facilitating increased market penetration of Electronic Medical Records (EMR) and providing precise and rapid findings, are anticipated to drive market expansion. Additionally, regulatory frameworks such as the Clean Air Act, Clean Water Act, and National Environmental Policy Act in the U.S. are expected to create growth opportunities for the regional market.

Meanwhile, the Middle East and Africa are poised to exhibit the fastest compound annual growth rate during the forecast period. This growth is attributed to significant unmet medical needs for diseases like cancer, diabetes, and other infectious diseases, coupled with improving healthcare expenditure, rising patient awareness, and increasing demand for home healthcare and point-of-care services. Government initiatives to reduce hospital stays through the development of outpatient care models further contribute to the region’s market growth.

Major Players in the Global Biosensors Market

The key players studied in the report are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Ascensia Diabetes Care Holdings AG, Biosensors International Group, Ltd, Siemens Healthineers AG, Bio-Rad Laboratories, Inc, among others.

COVID-19 Impact

The COVID-19 pandemic has exerted a profound impact on the biosensors market, both disrupting and steering its growth trajectory. Initially, the market experienced setbacks due to supply chain disruptions, lockdowns, and a reduced focus on non-essential healthcare products. However, as the pandemic unfolded, biosensors played a pivotal role in the rapid detection of the virus, driving increased demand for diagnostic applications. The emphasis on monitoring and early detection of infectious diseases has not only accelerated innovation in biosensor technology but has also created new opportunities for market expansion, particularly in the healthcare and diagnostics sectors. The pandemic has underscored the critical role that biosensors can play in public health crises, fueling investments, research, and development in the field, ultimately reshaping the landscape of the biosensors market.

Recent Developments

  • In January 2023, Intricon Corporation announced the opening of a Bionsensor Center of Excellence (CoE). The center aims to vertically integrate the company’s business to provide biosensors in medical devices.
  • In May 2020, Philips has received FDA clearance for its wearable biosensor, the Philips Biosensor BX100, designed to assist in managing confirmed and suspected COVID-19 patients in hospitals. This wireless biosensor, already in use at the OLVG Hospital in the Netherlands, enhances clinical surveillance by detecting vital signs and supporting early intervention for patients in lower acuity care areas. The disposable biosensor, with a 5-day usage cycle, adheres discreetly to the chest, transmitting respiratory and heart rates, along with contextual parameters, without the need for cleaning or charging. The device is part of Philips’ patient deterioration detection solution, providing a scalable and integrated approach to monitoring multiple patients across various rooms.

Frequently Asked Questions

Q1. How big is the Biosensors market?

Ans. The global Biosensors market was valued at approximately USD 26.4 billion in 2022 and it is anticipated to grow further to nearly USD 51.5 billion by 2032, at a CAGR of 6.9% during the forecast period.

Q2. What is the Biosensors market growth rate?

Ans. The growth rate of the Biosensors market is 6.9%.

Q3. Which region holds a major market share for the Biosensors market?

Ans. North America holds a major market share of the Biosensors market in 2022.

Q4. Which segment accounted for the largest Biosensors market share?

Ans. By end user, Point of Care Testing segment accounted for the largest Biosensors market share.

Q5. Who are the key players in the Biosensors market?

Ans. The global Biosensors market report includes players such as Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Ascensia Diabetes Care Holdings AG, Biosensors International Group, Ltd, Siemens Healthineers AG, Bio-Rad Laboratories, Inc, among others.

Q6. What are the factors driving the Biosensors market growth?

Ans. The major factors driving the growth of the market are the growing healthcare infrastructure in developed regions such as North America and Europe.

Q7. What are the key growth strategies of Biosensors market players?

Ans. The key growth strategies of Biosensors market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Biosensors market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Biosensors market during the forecast period.

 

Table of Contents

Chapter 1. Biosensors Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Scope of the Report
1.3. Report Limitations
1.4. Years & Currency Considered in the Study
1.5. Research Methodologies
1.5.1. Secondary Research
1.5.1.1. Data Collection
1.5.1.2. List of Secondary Sources
1.5.1.3. Key Data from Secondary Sources
1.5.2. Primary Research
1.5.2.1. List of Primary Research Sources
1.5.3. Market Technology Estimation: Top-Down Approach
1.5.4. Market Technology Estimation: Bottom-Up Approach
1.5.5. Data Triangulation and Validation

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
2.3. Analyst’s Review

Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Region
3.2. Market Attractiveness Analysis, by Type
3.3. Market Attractiveness Analysis, by Technology
3.4. Market Attractiveness Analysis, by Application
3.5. Market Attractiveness Analysis, by End-user

Chapter 4. Biosensors Market Outlook
4.1. Biosensors Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.6. Impact of COVID-19 on the Biosensors Market
4.7. Impact of the Russia and Ukraine War on the Biosensors Market
4.8. Parent Market Analysis
4.9. Biosensors Ecosystem Analysis
4.10. Case Study Analysis
4.11. Pricing Analysis
4.12. Regulatory Landscape
4.13. Patent Analysis
4.14. Technology Trend Analysis

Chapter 5. Biosensors Market, by Type
5.1. Market Overview
5.2. Wearable biosensors
5.2.1. Key Market Trends & Opportunity Analysis
5.2.2. Market Technology and Forecast, by Region
5.3. Non-wearable biosensors
5.3.1. Key Market Trends & Opportunity Analysis
5.3.2. Market Technology and Forecast, by Region

Chapter 6. Biosensors Market, by Technology
6.1. Market Overview
6.2. Electrochemical
6.2.1. Key Market Trends & Opportunity Analysis
6.2.2. Market Technology and Forecast, by Region
6.3. Optical
6.3.1. Key Market Trends & Opportunity Analysis
6.3.2. Market Technology and Forecast, by Region
6.4. Thermal
6.4.1. Key Market Trends & Opportunity Analysis
6.4.2. Market Technology and Forecast, by Region
6.5. Piezoelectric
6.5.1. Key Market Trends & Opportunity Analysis
6.5.2. Market Technology and Forecast, by Region
6.6. Others
6.6.1. Key Market Trends & Opportunity Analysis
6.6.2. Market Technology and Forecast, by Region

Chapter 7. Biosensors Market, by Application
7.1. Market Overview
7.2. Blood glucose testing
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. Market Technology and Forecast, by Region
7.3. Cholesterol testing
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Market Technology and Forecast, by Region
7.4. Blood gas analysis
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Market Technology and Forecast, by Region
7.5. Pregnancy testing
7.5.1. Key Market Trends & Opportunity Analysis
7.5.2. Market Technology and Forecast, by Region
7.6. Drug discovery
7.6.1. Key Market Trends & Opportunity Analysis
7.6.2. Market Technology and Forecast, by Region
7.7. Infectious disease testing
7.7.1. Key Market Trends & Opportunity Analysis
7.7.2. Market Technology and Forecast, by Region
7.8. Others
7.8.1. Key Market Trends & Opportunity Analysis
7.8.2. Market Technology and Forecast, by Region

Chapter 8. Biosensors Market, by End-user
8.1. Market Overview
8.2. Point of care testing
8.2.1. Key Market Trends & Opportunity Analysis
8.2.2. Market Technology and Forecast, by Region
8.3. Home healthcare diagnostics
8.3.1. Key Market Trends & Opportunity Analysis
8.3.2. Market Technology and Forecast, by Region
8.4. Research laboratories
8.4.1. Key Market Trends & Opportunity Analysis
8.4.2. Market Technology and Forecast, by Region
8.5. Others
8.5.1. Key Market Trends & Opportunity Analysis
8.5.2. Market Technology and Forecast, by Region

Chapter 9. Biosensors Market, by Region
9.1. Overview
9.2. North America
9.2.1. Key Market Trends and Opportunities
9.2.2. North America Biosensors Market Technology and Forecast, by Type
9.2.3. North America Biosensors Market Technology and Forecast, by Application
9.2.4. North America Biosensors Market Technology and Forecast, by Technology
9.2.5. North America Biosensors Market Technology and Forecast, by End-user
9.2.6. The U.S.
9.2.6.1. The U.S. Biosensors Market Technology and Forecast, by Type
9.2.6.2. The U.S. Biosensors Market Technology and Forecast, by Application
9.2.6.3. The U.S. Biosensors Market Technology and Forecast, by Technology
9.2.6.4. The U.S. Biosensors Market Technology and Forecast, by End-user
9.2.7. Canada
9.2.7.1. Canada Biosensors Market Technology and Forecast, by Type
9.2.7.2. Canada Biosensors Market Technology and Forecast, by Application
9.2.7.3. Canada Biosensors Market Technology and Forecast, by Technology
9.2.7.4. Canada Biosensors Market Technology and Forecast, by End-user
9.2.8. Mexico
9.2.8.1. Mexico Biosensors Market Technology and Forecast, by Type
9.2.8.2. Mexico Biosensors Market Technology and Forecast, by Application
9.2.8.3. Mexico Biosensors Market Technology and Forecast, by Technology
9.2.8.4. Mexico Biosensors Market Technology and Forecast, by End-user
9.3. Europe
9.3.1. Key Market Trends and Opportunities
9.3.2. Europe Biosensors Market Technology and Forecast, by Type
9.3.3. Europe Biosensors Market Technology and Forecast, by Application
9.3.4. Europe Biosensors Market Technology and Forecast, by Technology
9.3.5. Europe Biosensors Market Technology and Forecast, by End-user
9.3.6. Europe Biosensors Market Technology and Forecast, by Country
9.3.7. The UK
9.3.7.1. The UK Biosensors Market Technology and Forecast, by Type
9.3.7.2. The UK Biosensors Market Technology and Forecast, by Application
9.3.7.3. The UK Biosensors Market Technology and Forecast, by Technology
9.3.7.4. The UK Biosensors Market Technology and Forecast, by End-user
9.3.8. Germany
9.3.8.1. Germany Biosensors Market Technology and Forecast, by Type
9.3.8.2. Germany Biosensors Market Technology and Forecast, by Application
9.3.8.3. Germany Biosensors Market Technology and Forecast, by Technology
9.3.8.4. Germany Biosensors Market Technology and Forecast, by End-user
9.3.9. France
9.3.9.1. France Biosensors Market Technology and Forecast, by Type
9.3.9.2. France Biosensors Market Technology and Forecast, by Application
9.3.9.3. France Biosensors Market Technology and Forecast, by Technology
9.3.9.4. France Biosensors Market Technology and Forecast, by End-user
9.3.10. Spain
9.3.10.1. Spain Biosensors Market Technology and Forecast, by Type
9.3.10.2. Spain Biosensors Market Technology and Forecast, by Application
9.3.10.3. Spain Biosensors Market Technology and Forecast, by Technology
9.3.10.4. Spain Biosensors Market Technology and Forecast, by End-user
9.3.11. Italy
9.3.11.1. Italy Biosensors Market Technology and Forecast, by Type
9.3.11.2. Italy Biosensors Market Technology and Forecast, by Application
9.3.11.3. Italy Biosensors Market Technology and Forecast, by Technology
9.3.11.4. Italy Biosensors Market Technology and Forecast, by End-user
9.3.12. Netherlands
9.3.12.1. Netherlands Biosensors Market Technology and Forecast, by Type
9.3.12.2. Netherlands Biosensors Market Technology and Forecast, by Application
9.3.12.3. Netherlands Biosensors Market Technology and Forecast, by Technology
9.3.12.4. Netherlands Biosensors Market Technology and Forecast, by End-user
9.3.13. Sweden
9.3.13.1. Sweden Biosensors Market Technology and Forecast, by Type
9.3.13.2. Sweden Biosensors Market Technology and Forecast, by Application
9.3.13.3. Sweden Biosensors Market Technology and Forecast, by Technology
9.3.13.4. Sweden Biosensors Market Technology and Forecast, by End-user
9.3.14. Switzerland
9.3.14.1. Switzerland Biosensors Market Technology and Forecast, by Type
9.3.14.2. Switzerland Biosensors Market Technology and Forecast, by Application
9.3.14.3. Switzerland Biosensors Market Technology and Forecast, by Technology
9.3.14.4. Switzerland Biosensors Market Technology and Forecast, by End-user
9.3.15. Denmark
9.3.15.1. Denmark Biosensors Market Technology and Forecast, by Type
9.3.15.2. Denmark Biosensors Market Technology and Forecast, by Application
9.3.15.3. Denmark Biosensors Market Technology and Forecast, by Technology
9.3.15.4. Denmark Biosensors Market Technology and Forecast, by End-user
9.3.16. Finland
9.3.16.1. Finland Biosensors Market Technology and Forecast, by Type
9.3.16.2. Finland Biosensors Market Technology and Forecast, by Application
9.3.16.3. Finland Biosensors Market Technology and Forecast, by Technology
9.3.16.4. Finland Biosensors Market Technology and Forecast, by End-user
9.3.17. Russia
9.3.17.1. Russia Biosensors Market Technology and Forecast, by Type
9.3.17.2. Russia Biosensors Market Technology and Forecast, by Application
9.3.17.3. Russia Biosensors Market Technology and Forecast, by Technology
9.3.17.4. Russia Biosensors Market Technology and Forecast, by End-user
9.3.18. Rest of Europe
9.3.18.1. Rest of Europe Biosensors Market Technology and Forecast, by Type
9.3.18.2. Rest of Europe Biosensors Market Technology and Forecast, by Application
9.3.18.3. Rest of Europe Biosensors Market Technology and Forecast, by Technology
9.3.18.4. Rest of Europe Biosensors Market Technology and Forecast, by End-user
9.4. Asia-Pacific
9.4.1. Key Market Trends and Opportunities
9.4.2. Asia-Pacific Biosensors Market Technology and Forecast, by Type
9.4.3. Asia-Pacific Biosensors Market Technology and Forecast, by Application
9.4.4. Asia-Pacific Biosensors Market Technology and Forecast, by Technology
9.4.5. Asia-Pacific Biosensors Market Technology and Forecast, by End-user
9.4.6. Asia-Pacific Biosensors Market Technology and Forecast, by Country
9.4.7. China
9.4.7.1. China Biosensors Market Technology and Forecast, by Type
9.4.7.2. China Biosensors Market Technology and Forecast, by Application
9.4.7.3. China Biosensors Market Technology and Forecast, by Technology
9.4.7.4. China Biosensors Market Technology and Forecast, by End-user
9.4.8. India
9.4.8.1. India Biosensors Market Technology and Forecast, by Type
9.4.8.2. India Biosensors Market Technology and Forecast, by Application
9.4.8.3. India Biosensors Market Technology and Forecast, by Technology
9.4.8.4. India Biosensors Market Technology and Forecast, by End-user
9.4.9. Japan
9.4.9.1. Japan Biosensors Market Technology and Forecast, by Type
9.4.9.2. Japan Biosensors Market Technology and Forecast, by Application
9.4.9.3. Japan Biosensors Market Technology and Forecast, by Technology
9.4.9.4. Japan Biosensors Market Technology and Forecast, by End-user
9.4.10. South Korea
9.4.10.1. South Korea Biosensors Market Technology and Forecast, by Type
9.4.10.2. South Korea Biosensors Market Technology and Forecast, by Application
9.4.10.3. South Korea Biosensors Market Technology and Forecast, by Technology
9.4.10.4. South Korea Biosensors Market Technology and Forecast, by End-user
9.4.11. Australia
9.4.11.1. Australia Biosensors Market Technology and Forecast, by Type
9.4.11.2. Australia Biosensors Market Technology and Forecast, by Application
9.4.11.3. Australia Biosensors Market Technology and Forecast, by Technology
9.4.11.4. Australia Biosensors Market Technology and Forecast, by End-user
9.4.12. Singapore
9.4.12.1. Singapore Biosensors Market Technology and Forecast, by Type
9.4.12.2. Singapore Biosensors Market Technology and Forecast, by Application
9.4.12.3. Singapore Biosensors Market Technology and Forecast, by Technology
9.4.12.4. Singapore Biosensors Market Technology and Forecast, by End-user
9.4.13. Indonesia
9.4.13.1. Indonesia Biosensors Market Technology and Forecast, by Type
9.4.13.2. Indonesia Biosensors Market Technology and Forecast, by Application
9.4.13.3. Indonesia Biosensors Market Technology and Forecast, by Technology
9.4.13.4. Indonesia Biosensors Market Technology and Forecast, by End-user
9.4.13.5. Indonesia Biosensors Market Technology and Forecast, by Application
9.4.14. Taiwan
9.4.14.1. Taiwan Biosensors Market Technology and Forecast, by Type
9.4.14.2. Taiwan Biosensors Market Technology and Forecast, by Application
9.4.14.3. Taiwan Biosensors Market Technology and Forecast, by Technology
9.4.14.4. Taiwan Biosensors Market Technology and Forecast, by End-user
9.4.15. Malaysia
9.4.15.1. Malaysia Biosensors Market Technology and Forecast, by Type
9.4.15.2. Malaysia Biosensors Market Technology and Forecast, by Application
9.4.15.3. Malaysia Biosensors Market Technology and Forecast, by Technology
9.4.15.4. Malaysia Biosensors Market Technology and Forecast, by End-user
9.4.16. Rest of Asia-Pacific
9.4.16.1. Rest of Asia-Pacific Biosensors Market Technology and Forecast, by Type
9.4.16.2. Rest of Asia-Pacific Biosensors Market Technology and Forecast, by Application
9.4.16.3. Rest of Asia-Pacific Biosensors Market Technology and Forecast, by Technology
9.4.16.4. Rest of Asia-Pacific Biosensors Market Technology and Forecast, by End-user
9.5. Rest of the World
9.5.1. Key Market Trends and Opportunities
9.5.2. Rest of the World Biosensors Market Technology and Forecast, by Type
9.5.3. Rest of the World Biosensors Market Technology and Forecast, by Application
9.5.4. Rest of the World Biosensors Market Technology and Forecast, by Technology
9.5.5. Rest of the World Biosensors Market Technology and Forecast, by End-user
9.5.6. Rest of the World Biosensors Market Technology and Forecast, by Country
9.5.7. Latin America
9.5.7.1. Latin America Biosensors Market Technology and Forecast, by Type
9.5.7.2. Latin America Biosensors Market Technology and Forecast, by Application
9.5.7.3. Latin America Biosensors Market Technology and Forecast, by Technology
9.5.7.4. Latin America Biosensors Market Technology and Forecast, by End-user
9.5.8. Middle East
9.5.8.1. Middle East Biosensors Market Technology and Forecast, by Type
9.5.8.2. Middle East Biosensors Market Technology and Forecast, by Application
9.5.8.3. Middle East Biosensors Market Technology and Forecast, by Technology
9.5.8.4. Middle East Biosensors Market Technology and Forecast, by End-user
9.5.9. Africa
9.5.9.1. Africa Biosensors Market Technology and Forecast, by Type
9.5.9.2. Africa Biosensors Market Technology and Forecast, by Application
9.5.9.3. Africa Biosensors Market Technology and Forecast, by Technology
9.5.9.4. Africa Biosensors Market Technology and Forecast, by End-user

Chapter 10. Competitive Landscape
10.1. Overview
10.2. Market Share Analysis/Key Player Positioning
10.3. Competitive Leadership Mapping
10.3.1. Star Players
10.3.2. Innovators
10.3.3. Emerging Players
10.4. Vendor Benchmarking
10.5. Developmental Strategy Benchmarking
10.5.1. New Product Developments
10.5.2. Product Launches
10.5.3. Business Expansions
10.5.4. Partnerships, Joint Ventures, and Collaborations
10.5.5. Mergers and Acquisitions

Chapter 11. Company Profiles
11.1. F. Hoffmann-La Roche Ltd
11.1.1. Company Overview
11.1.2. Company Snapshot
11.1.3. Business Segments
11.1.4. Business Performance
11.1.5. Product offerings
11.1.6. Key Developmental Strategies
11.1.7. SWOT Analysis
11.2. Abbott Laboratories
11.2.1. Company Overview
11.2.2. Company Snapshot
11.2.3. Business Segments
11.2.4. Business Performance
11.2.5. Product offerings
11.2.6. Key Developmental Strategies
11.2.7. SWOT Analysis
11.3. Thermo Fisher Scientific Inc.
11.3.1. Company Overview
11.3.2. Company Snapshot
11.3.3. Business Segments
11.3.4. Business Performance
11.3.5. Product offerings
11.3.6. Key Developmental Strategies
11.3.7. SWOT Analysis
11.4. Danaher Corporation
11.4.1. Company Overview
11.4.2. Company Snapshot
11.4.3. Business Segments
11.4.4. Business Performance
11.4.5. Product offerings
11.4.6. Key Developmental Strategies
11.4.7. SWOT Analysis
11.5. Siemens Healthineers AG
11.5.1. Company Overview
11.5.2. Company Snapshot
11.5.3. Business Segments
11.5.4. Business Performance
11.5.5. Product offerings
11.5.6. Key Developmental Strategies
11.5.7. SWOT Analysis
11.6. Ascensia Diabetes Care Holdings AG
11.6.1. Company Overview
11.6.2. Company Snapshot
11.6.3. Business Segments
11.6.4. Business Performance
11.6.5. Product offerings
11.6.6. Key Developmental Strategies
11.6.7. SWOT Analysis
11.7. Bio-Rad Laboratories, Inc
11.7.1. Company Overview
11.7.2. Company Snapshot
11.7.3. Business Segments
11.7.4. Business Performance
11.7.5. Product offerings
11.7.6. Key Developmental Strategies
11.7.7. SWOT Analysis
11.8. Biosensors International Group, Ltd
11.8.1. Company Overview
11.8.2. Company Snapshot
11.8.3. Business Segments
11.8.4. Business Performance
11.8.5. Product offerings
11.8.6. Key Developmental Strategies
11.8.7. SWOT Analysis
11.9. Dexcom, Inc.
11.9.1. Company Overview
11.9.2. Company Snapshot
11.9.3. Business Segments
11.9.4. Business Performance
11.9.5. Product offerings
11.9.6. Key Developmental Strategies
11.9.7. SWOT Analysis
11.10. LifeScan Inc.
11.10.1. Company Overview
11.10.2. Company Snapshot
11.10.3. Business Segments
11.10.4. Business Performance
11.10.5. Product offerings
11.10.6. Key Developmental Strategies
11.10.7. SWOT Analysis
11.11. Masimo
11.11.1. Company Overview
11.11.2. Company Snapshot
11.11.3. Business Segments
11.11.4. Business Performance
11.11.5. Product offerings
11.11.6. Key Developmental Strategies
11.11.7. SWOT Analysis
11.12. Nova Biomedical
11.12.1. Company Overview
11.12.2. Company Snapshot
11.12.3. Business Segments
11.12.4. Business Performance
11.12.5. Product offerings
11.12.6. Key Developmental Strategies
11.12.7. SWOT Analysis
11.13. Pinnacle Technology
11.13.1. Company Overview
11.13.2. Company Snapshot
11.13.3. Business Segments
11.13.4. Business Performance
11.13.5. Product offerings
11.13.6. Key Developmental Strategies
11.13.7. SWOT Analysis
11.14. QTL Biosystems
11.14.1. Company Overview
11.14.2. Company Snapshot
11.14.3. Business Segments
11.14.4. Business Performance
11.14.5. Product offerings
11.14.6. Key Developmental Strategies
11.14.7. SWOT Analysis
11.15. TE Connectivity Corporati
11.15.1. Company Overview
11.15.2. Company Snapshot
11.15.3. Business Segments
11.15.4. Business Performance
11.15.5. Product offerings
11.15.6. Key Developmental Strategies
11.15.7. SWOT Analysis
*The list of companies is subject to change during the final compilation of the report

Key Players
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Siemens Healthineers AG
  • Ascensia Diabetes Care Holdings AG
  • Bio-Rad Laboratories, Inc
  • Biosensors International Group, Ltd
  • Dexcom, Inc.
  • LifeScan Inc.
  • Masimo
  • Nova Biomedical
  • Pinnacle Technology
  • QTL Biosystems
  • TE Connectivity Corporation
Market Segments

By Type

  • Wearable biosensors
  • Non-wearable biosensors

By Technology

  • Electrochemical
  • Optical
  • Thermal
  • Piezoelectric
  • Others

By Application

  • Blood glucose testing
  • Cholesterol testing
  • Blood gas analysis
  • Pregnancy testing
  • Drug discovery
  • Infectious disease testing
  • Others

By End-User

  • Point of care testing
  • Home healthcare diagnostics
  • Research laboratories
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Russia
    • Rest of Europe
  • The Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Singapore
    • Indonesia
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • The Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

A railway connector is a device that is…
F-Type RF coaxial connector is a type of…
Power Tools Market technology is a type of…
A Wi-Fi chipset is a semiconductor device that…
Swarm robotics is a type of distributed robotic…
Semiconductor metrology and inspection is the process of…
Ultrasonic sensors are sensors that use sound waves…
A circuit breaker based transfer switch, also known…
Data center power market is a segment of…
A smartphone is a handheld personal computer with…